- Founded
- 2009
- Status
- Private
- LSVP Investment
- 2018
- Stage Invested
- Seed-2
Medikine utilizes a proprietary platform to identify agonists of clinically relevant heterodimeric cytokine receptors for the development of novel therapeutics for immuno-oncology applications in cell therapy and neo-antigen vaccines.